XML 36 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Supplemental Financial Statement Information (Tables)
9 Months Ended
Sep. 30, 2022
Additional Financial Information Disclosure [Abstract]  
Summary of Cash Equivalents and Short-Term Investments
The following tables summarize the cost or amortized cost, gross unrealized gain, gross unrealized loss and fair value of the Company’s cash equivalents and short-term investments as of the dates indicated (in thousands):
September 30, 2022
Cost or
Amortized
Cost
UnrealizedEstimated
Fair Value
GainsLosses
Unrestricted Balances(1)
Money market funds$1,885 $— $— $1,885 
Money market deposit accounts51,318 — — 51,318 
Term deposits15,000 — — 15,000 
Certificates of deposit430,038 122 (801)429,359 
Commercial paper1,085,841 62 (2,631)1,083,272 
Corporate bonds85,821 — (675)85,146 
U.S. government securities39,750 — (34)39,716 
Total unrestricted cash equivalents and short-term investments1,709,653 184 (4,141)1,705,696 
Restricted Balances(2)
Money market funds91,231 — — 91,231 
Term deposits5,046 — — 5,046 
Certificates of deposit269,915 52 (680)269,287 
Commercial paper660,339 44 (1,190)659,193 
Corporate bonds29,158 — (151)29,007 
U.S. government securities63,622 — (282)63,340 
Total restricted cash equivalents and investments1,119,311 96 (2,303)1,117,104 
Total unrestricted and restricted cash equivalents and investments$2,828,964 $280 $(6,444)$2,822,800 
_______________
(1)Excludes $72.8 million of cash and $4.9 million of marketable equity securities, which are included within the $1.8 billion of cash and cash equivalents and short-term investments on the condensed consolidated balance sheets.
(2)Excludes $56.1 million of restricted cash, which is included within the $1.2 billion of restricted cash and cash equivalents and restricted short-term investments on the condensed consolidated balance sheets.
December 31, 2021
Cost or
Amortized
Cost
UnrealizedEstimated
Fair Value
GainsLosses
Unrestricted Balances(1)
Money market funds$22,250 $— $— $22,250 
Money market deposit accounts330,252 — — 330,252 
Term deposits385,000 — — 385,000 
Certificates of deposit505,562 25 (149)505,438 
Commercial paper806,446 132 (190)806,388 
Corporate bonds99,779 (78)99,705 
Total unrestricted cash equivalents and short-term investments2,149,289 161 (417)2,149,033 
Restricted Balances(2)
Money market funds20,161 — — 20,161 
Term deposits5,046 — — 5,046 
Certificates of deposit421,243 35 (134)421,144 
Commercial paper523,616 43 (169)523,490 
Corporate bonds63,506 — (48)63,458 
U.S. government securities31,745 — (28)31,717 
Total restricted cash equivalents and investments1,065,317 78 (379)1,065,016 
Total unrestricted and restricted cash equivalents and investments$3,214,606 $239 $(796)$3,214,049 
_______________
(1)Excludes $104.8 million of cash, which is included within the $2.3 billion of cash and cash equivalents and short-term investments on the condensed consolidated balance sheets.
(2)Excludes $53.7 million of restricted cash, which is included within the $1.1 billion of restricted cash and cash equivalents and restricted short-term investments on the condensed consolidated balance sheets.
Schedule of AFS Debt Securities The following table summarizes the Company’s available-for-sale debt securities in an unrealized loss position for which no allowance for credit losses was recorded, aggregated by major security type (in thousands):
September 30, 2022
Estimated Fair ValueUnrealized Losses
Certificates of deposit$463,826 $(1,481)
Corporate bonds 114,153 (826)
Commercial paper1,523,046 (3,821)
U.S. government securities103,055 (316)
Total available-for-sale debt securities in an unrealized loss position $2,204,080 $(6,444)
Schedule of Accrued and Other Current Liabilities
Accrued and other current liabilities consisted of the following as of the dates indicated (in thousands):
September 30, 2022December 31, 2021
Legal accruals$389,540 $349,518 
Insurance-related accruals384,729 336,340 
Ride-related accruals208,477 196,716 
Long-term debt, current38,233 56,264 
Insurance claims payable and related fees36,695 33,696 
Deferred gain related to the Reinsurance Transaction (1)
2,357 52,785 
Other322,575 239,107 
Accrued and other current liabilities$1,382,606 $1,264,426 
_______________
(1)Refer to Note 2 “Summary of Significant Accounting Policies” above and the rest of this Note 5 “Supplemental Financial Information - Insurance Reserves” below for more information on this deferred gain.
Summary of Roll-Forward of the Insurance Reserve
The following table provides a rollforward of the insurance reserve for the periods presented (in thousands):
Nine Months Ended September 30,
20222021
Balance at beginning of period$1,068,628 $987,064 
Reinsurance recoverable at beginning of period(245,179)(251,328)
Additions related to:
Reserves for current period210,905 227,478 
Change in estimates for prior periods368,280 128,045 
Losses paid(388,344)(329,805)
Adjustments related to Commutation Transaction(1)
247,438 — 
Transfer of certain legacy auto insurance liabilities— — 
Net balance at the end of the period1,261,728 761,454 
Add: Reinsurance recoverable at the end of the period4,000 249,699 
Balance at end of period$1,265,728 $1,011,153 
_______________
(1)In the second quarter of 2022, the Company completed the Commutation Transaction, which effectively commuted and settled the previous Reinsurance Agreement. See below for more details of the "Commutation of the Reinsurance Agreement".
Schedule of Other Income (Expense), Net
The following table sets forth the primary components of other income, net as reported on the condensed consolidated statements of operations (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Interest income$12,945 $1,923 $20,321 $7,008 
Gain (loss) on sale of securities, net(28)(17)(61)685 
Foreign currency exchange gains (losses), net(7,121)736 (6,436)1,212 
Sublease income2,555 2,947 10,099 2,947 
Gain from transaction with Woven Planet— 119,284 — 119,284 
Impairment charges(1)
(135,714)— (135,714)— 
Other, net1,208 169 (3,648)(748)
Other income (expense), net$(126,155)$125,042 $(115,439)$130,388 
_______________(1)In the third quarter of 2022, the Company impaired the entire amount of a non-marketable equity investment in addition to other assets with the investee. This impairment was triggered due to the announced winding down of the equity investee. Refer to Note 6 "Fair Value Measurements" for additional details.